Retifanlimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Retifanlimab Usage And Synthesis

Uses

Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1].

References

[1] D V T Catenacci, et al. Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A. ESMO Open. 2022 Oct;7(5):100563. DOI:10.1016/j.esmoop.2022.100563

Retifanlimab(2079108-44-2)Related Product Information

• Quetmolimab
• Plonmarlimab
• OregovoMab
• Mitumomab
• Eblasakimab
• Indatuximab Ravtansine
• Elranatamab
• Navivumab
• Idarucizumab
• Ezabenlimab